A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery
Completed · Phase 2
Conditions studied: Thrombosis, Hip Replacement
In brief
This study is to assess if DU176b is effective in prevention of blood clots following hip replacement surgery. The duration is 7-10 days of treatment and 30 and 60 day follow-up visits.
Key facts
- Study ID
- NCT00398216
- Run by
- Daiichi Sankyo
- People needed
- 903
- Starts
- 2006-05-01
- Expected to finish
- 2007-06-01
- Last updated by the study team
- 2019-02-26
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Study site — Hartford, Connecticut, United States
- Study site — Sarasota, Florida, United States
- Study site — Austin, Texas, United States
- Study site — Ajax, Ontario, Canada
- Study site — Cambridge, Ontario, Canada
- Study site — Guelph, Ontario, Canada
- Study site — Kitchner, Ontario, Canada
- Study site — Toronto, Ontario, Canada
- Study site — Hellerup, Denmark
- Study site — Herlev, Denmark
- Study site — Hørsholm, Denmark
- Study site — Gyula, Hungary
- Study site — Kecskemét, Hungary
- Study site — Szeged, Hungary
- Study site — Riga, Latvia
- Study site — Krasnoyarsk, Russia
- Study site — Moscow, Russia
- Study site — Saint Petersburg, Russia
- Study site — Saratov, Russia
- Study site — Veliky Novgorod, Russia
- Study site — Volgograd, Russia
- Study site — Chernivtsy, Ukraine
- Study site — Dnipro, Ukraine
- Study site — Donetsk, Ukraine
- Study site — Kharkiv, Ukraine
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.